FDA approval for the Agent drug-coated balloon to treat coronary in-stent restenosis in patients with coronary artery disease – Boston Scientific
Boston Scientific Corporation announced it has received FDA approval for the Agent Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary… read more.